In pulmonary embolism, systemic anticoagulation is the cornerstone treatment. Unless a specific contraindication exists, professional guidelines recommend LMWH and DOACs over UFH for the majority ...

The NHS dietician was diagnosed as probably having a Pulmonary Embolism – a blood clot in the lung – but died after she failed to receive the treatment she needed and which probably would have ...

A pulmonary embolism is the most common pathology of a pulmonary angiogram. Options for treatment of a pulmonary embolism include: Pulmonary angiography of the lungs involves tests that examine ...

In the era of DOACs, risk for CTEPH following pulmonary embolism is affected by multiple factors, including gender and heart load.

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, ...

AngioDynamics, Inc. (ANGO), a New York-based medical technology company Monday announced the publication of results from the Acute ...

A recent review of the programme showed that 0.3% of almost 12,000 CT scans were positive for pulmonary embolism. The wait time for these patients to get a diagnosis and start a treatment plan was ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...